Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice-4

M + olmesartan medoxomil 1 mg/kg group. Increased fibrosis with definite damage to the lung structure and formation of small fibrous masses were partially observed. (c) BLM + PD 5 mg/kg group. Increased fibrosis with definite damage to the lung structure and formation of small fibrous masses were partially observed. (d) Control group. The normal alveolar structure is visible. (Azan-Mallory × 40)<p><b>Copyright information:</b></p><p>Taken from "Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice"</p><p>http://respiratory-research.com/content/9/1/43</p><p>Respiratory Research 2008;9(1):43-43.</p><p>Published online 23 May 2008</p><p>PMCID:PMC2409315.</p><p></p

Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice-1

*p < 0.05.<p><b>Copyright information:</b></p><p>Taken from "Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice"</p><p>http://respiratory-research.com/content/9/1/43</p><p>Respiratory Research 2008;9(1):43-43.</p><p>Published online 23 May 2008</p><p>PMCID:PMC2409315.</p><p></p

Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice-5

*p < 0.05.<p><b>Copyright information:</b></p><p>Taken from "Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice"</p><p>http://respiratory-research.com/content/9/1/43</p><p>Respiratory Research 2008;9(1):43-43.</p><p>Published online 23 May 2008</p><p>PMCID:PMC2409315.</p><p></p

Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice-0

M + olmesartan medoxomil 1 mg/kg group. Increased fibrosis with definite damage to the lung structure and formation of small fibrous masses were partially observed. (c) BLM + PD 5 mg/kg group. Increased fibrosis with definite damage to the lung structure and formation of small fibrous masses were partially observed. (d) Control group. The normal alveolar structure is visible. (Azan-Mallory × 40)<p><b>Copyright information:</b></p><p>Taken from "Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice"</p><p>http://respiratory-research.com/content/9/1/43</p><p>Respiratory Research 2008;9(1):43-43.</p><p>Published online 23 May 2008</p><p>PMCID:PMC2409315.</p><p></p